A A A A
 
Pages
Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Posts
Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Menu
 
 
Home | Meet The Team
 

Investigators

  • Prof. Andrew Biankin (University of Glasgow)
  • Dr David Chang (University of Glasgow)
  • Prof. Juan Valle (University of Manchester)
  • Prof. Owen Sansom (Cancer Research UK Beatson Institute)
  • Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit)
  • Prof. Caroline Dive (Cancer Research UK Manchester Institute)
  • Dr Claus Jorgensen (Cancer Research UK Manchester Institute)
  • Prof. Christopher Lord (Institute for Cancer Research)
  • Prof. Eric O’Neill (Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology)
  • Prof. Duncan Jodrell (Cancer Research UK Cambridge Institute) 
  • Dr. Susie Cooke (University of Glasgow)

Steering Committee

  • Prof. Andrew Biankin (University of Glasgow) (Chair)
  • Dr David Chang (University of Glasgow)
  • Dr. Susie Cooke (University of Glasgow)
  • Prof. Caroline Dive (Cancer Research UK Manchester Institute)
  • Ms Judith Dixon-Hughes (University of Glasgow)
  • Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit)
  • Dr Janet Graham (NHS Greater Glasgow and Clyde)
  • Dr Derek Grose (NHS Greater Glasgow and Clyde)
  • Prof. Duncan Jodrell (Cancer Research UK Cambridge Institute) 
  • Dr Claus Jorgensen (Cancer Research UK Manchester Institute)
  • Mrs Caroline Kelly (University of Glasgow
  • Prof. Hemant Kocher (Cancer Research UK Barts Centre)
  • Prof. Christopher Lord (Institute for Cancer Research)
  • Dr Lynn Matrisian (Chief Science Officer, Pancreatic Cancer Action Network)
  • Prof. Colin McKay (NHS Greater Glasgow and Clyde)
  • Prof. Jen Morton (University of Glasgow)
  • Prof. Eric O’Neill (Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology)
  • Prof. Owen Sansom (Cancer Research UK Beatson Institute)
  • Mr Jamie Stobo (University of Glasgow)
  • Ms Janice Tannock (PPI Representative)
  • Prof. Juan Valle (University of Manchester)
  • Dr Ian Walker (CRUK)

Therapeutic Testing Board

  • Prof. Owen Sansom (Cancer Research UK Beatson Institute) (Chair)
  • Dr Peter Bailey (University of Glasgow)
  • Mr Simon Barry (AstraZeneca)
  • Dr Philip Beer (University of Cambridge)
  • Prof. Andrew Biankin (University of Glasgow)
  • Dr David Chang (University of Glasgow)
  • Prof. Jeff Evans (Cancer Research UK Glasgow Clinical Trials Unit)
  • Dr Janet Graham (NHS Greater Glasgow and Clyde)
  • Prof. Duncan Jodrell (Cancer Research UK Cambridge Institute) 
  • Dr Claus Jorgensen (Cancer Research UK Manchester Institute)
  • Mr Caroline Kelly (University of Glasgow)
  • Prof. Christopher Lord (Institute for Cancer Research)
  • Dr Mairéad McNamara (The Christie NHS Foundation Trust)
  • Mr Peter Mortimer (AstraZeneca)
  • Prof. Jen Morton (University of Glasgow)
  • Prof. Eric O’Neill (Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology)
  • Mr Jamie Stobo (University of Glasgow)
  • Prof. Juan Valle (University of Manchester)

Scientific Advisory Board

  • Prof. John Primrose (Chair)
  • Dr Ultan McDermott (Chief Scientist at AstraZeneca)
  • Prof. Gary Middleton (Medical Oncologist, University of Birmingham)
  • Dr Serena Nik-Zainal (CRUK Advanced Clinical Scientist, University of Cambridge)
  • Prof. Dieter Saur (Consultant of Gastroenterology, Technical University of Munich)
  • Prof. Rosie Sears (Co-director, Brenden-Colson Centre for Pancreatic Cancer, Portland, Oregon)
  • Prof. Charles Swanton (Senior Group leader, Francis Crick Institute)
  • Janice Tannock (Consumer Representative)
© 2019 Precision Panc
Web design by Creatomatic
This site uses cookies.
Configure
 
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.